Table 1.

Baseline characteristics of the ULSAM cohort

Subjects, n	741
Age, years	77.5 ± 0.8
Body mass index	26.3 ± 3.5
Systolic blood pressure, mm Hg	151 ± 21
Diastolic blood pressure, mm Hg	81 ± 10
Urinary albumin/creatinine ratio	0.8 (0.3 – 2.1)
Glomerular filtration ratea	73 ± 17
Total cholesterol, mmol/L	5.4 ± 1.0
HDL cholesterol, mmol/L	1.3 ± 0.3
Fasting plasma glucose, mmol/L	5.8 ± 1.2
C-reactive protein, mg/L	1.8 (0.96 – 4.2)
Interleukin 6, ng/L	2.9 (2.1 – 4.9)
Plasma osteopontin, ng/mL	55 ± 26
Urinary osteopontin, ng/mLb	113 ± 64
Lipid-lowering treatment	125 (17)
Antihypertensive treatment	352 (48)
Acetylsalicylic acid	213 (29)
Chronic kidney disease	155 (21)
Cardiovascular disease	204 (28)
Ischemic heart disease	140 (19)
Cerebrovascular disease	73 (10)
Congestive heart failure	35 (5)
Diabetes	86 (12)
Smoking	59 (8)

Normally distributed continuous variables are presented as means ± standard deviations, skewed continuous variables as medians (interquartile ranges; IQR25–IQR75), and categorical variables as n (%). HDL, high-density lipoprotein.

^aGlomerular filtration rate was estimated from serum cystatin C (mL/min/1.73 m²).

^bCreatinine-adjusted osteopontin.